Sec. 405. Disallowance of deduction for advertising for prescription drugs
233 words·~1 min read·
/bill/115/hr/1776/ih/section-405A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Part IX of subchapter B of chapter 1 of subtitle A of the Internal Revenue Code of 1986 (relating to items not deductible) is amended by adding at the end the following new section: No deduction shall be allowed under this chapter for expenses relating to direct-to-consumer advertising of prescription drugs for any taxable year. For purposes of this section, the term direct-to-consumer advertising means any dissemination, by or on behalf of a sponsor of a prescription drug product (as such term is defined in section 735(3) of the Federal Food, Drug, and Cosmetic Act), of an advertisement which— is in regard to such prescription drug product, and primarily targeted to the general public, including through— publication in journals, magazines, other periodicals, and newspapers, broadcasting through media such as radio, television, telephone communication systems, direct mail, and billboards, dissemination on the Internet (including social media); and manufacturer patient assistance programs, as defined in section 399V–7 of the Public Health Service Act. .
The table of sections for such part IX of the Internal Revenue Code of 1986 is amended by adding after the item relating to section 280H the following new item: Sec. 280I. Disallowance of deduction for direct-to-consumer advertising of prescription drugs. . The amendments made by this section shall apply to amounts paid or incurred after the date of the enactment of this Act, in taxable years ending after such date.